AmbioPharm provides our customers with a full range of services to produce peptide APIs (Active Pharmaceutical Ingredients) at varying scales from gram to multi-kilogram scale.
We use solid phase synthesis, solution phase synthesis, and hybrid solid/solution phase synthesis to produce peptide APIs.
From preclinical to commercial, AmbioPharm has multiple manufacturing suites capable of handling any project scale. AmbioPharm’s unique business model is designed to handle efficient and swift peptide manufacturing. We can produce the highest-quality products of any scale at a lower price than most competitors.